γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy

F. Martini, R. Urso, C. Gioia, A. De Felici, P. Narciso, A. Amendola, M. G. Paglia, V. Colizzi, F. Poccia

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

γδ T lymphocytes recognize non-peptidic microbial antigens without antigen processing and major histocompatibility complex (MHC) restriction, representing an early defence mechanism against invading pathogens. As a defective response to non-peptidic antigens was observed in human immunodeficiency virus-positive (HIV+) persons, the aims of this study were twofold: to analyse the incidence of γδ T-cell anergy in HIV+ patients with opportunistic infections/co-infections (HIV-OIC), and to investigate the role of highly active antiretroviral therapy (HAART) on γδ T-cell functions. Peripheral γδ T-cell distribution and in vitro reactivity to a non-peptidic mycobacterial antigen, isopentenyl pyrophosphate (IPP), were analysed. γδ T-cell subset distribution was altered more in HIV-OIC patients than in asymptomatic HIV+ subjects (HIV-ASY). Specifically, the Vδ2/Vδ1 ratio was inverted as a consequence of a decrease in Vδ2 T-cell number. Moreover, IPP-stimulated Vδ2 T cells from the HIV-OIC group displayed a major defect in interferon-γ (IFN-γ) production. Interestingly, HAART induced a sustained recovery of naive CD45RA+ and CD62L+ T cells and restored γδ T-cell function. Accordingly, in vitro CD45RA depletion resulted in γδ T-cell hyporesponsiveness. Altogether, the incidence of γδ T-cell anergy was increased in HIV-OIC patients and dependent on CD45RA helper function. Moreover, HAART was able to restore γδ T-cell reactivity, extending the immune recovery to non-peptidic microbial antigens.

Original languageEnglish
Pages (from-to)481-486
Number of pages6
JournalImmunology
Volume100
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Opportunistic Infections
Highly Active Antiretroviral Therapy
HIV
T-Lymphocytes
Coinfection
Antigens
Incidence
Antigen Presentation
T-Lymphocyte Subsets
Major Histocompatibility Complex
Interferons
Cell Count

ASJC Scopus subject areas

  • Immunology

Cite this

γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. / Martini, F.; Urso, R.; Gioia, C.; De Felici, A.; Narciso, P.; Amendola, A.; Paglia, M. G.; Colizzi, V.; Poccia, F.

In: Immunology, Vol. 100, No. 4, 2000, p. 481-486.

Research output: Contribution to journalArticle

@article{01bda514699d4ddca57a78713f94550b,
title = "γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy",
abstract = "γδ T lymphocytes recognize non-peptidic microbial antigens without antigen processing and major histocompatibility complex (MHC) restriction, representing an early defence mechanism against invading pathogens. As a defective response to non-peptidic antigens was observed in human immunodeficiency virus-positive (HIV+) persons, the aims of this study were twofold: to analyse the incidence of γδ T-cell anergy in HIV+ patients with opportunistic infections/co-infections (HIV-OIC), and to investigate the role of highly active antiretroviral therapy (HAART) on γδ T-cell functions. Peripheral γδ T-cell distribution and in vitro reactivity to a non-peptidic mycobacterial antigen, isopentenyl pyrophosphate (IPP), were analysed. γδ T-cell subset distribution was altered more in HIV-OIC patients than in asymptomatic HIV+ subjects (HIV-ASY). Specifically, the Vδ2/Vδ1 ratio was inverted as a consequence of a decrease in Vδ2 T-cell number. Moreover, IPP-stimulated Vδ2 T cells from the HIV-OIC group displayed a major defect in interferon-γ (IFN-γ) production. Interestingly, HAART induced a sustained recovery of naive CD45RA+ and CD62L+ T cells and restored γδ T-cell function. Accordingly, in vitro CD45RA depletion resulted in γδ T-cell hyporesponsiveness. Altogether, the incidence of γδ T-cell anergy was increased in HIV-OIC patients and dependent on CD45RA helper function. Moreover, HAART was able to restore γδ T-cell reactivity, extending the immune recovery to non-peptidic microbial antigens.",
author = "F. Martini and R. Urso and C. Gioia and {De Felici}, A. and P. Narciso and A. Amendola and Paglia, {M. G.} and V. Colizzi and F. Poccia",
year = "2000",
doi = "10.1046/j.1365-2567.2000.00068.x",
language = "English",
volume = "100",
pages = "481--486",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy

AU - Martini, F.

AU - Urso, R.

AU - Gioia, C.

AU - De Felici, A.

AU - Narciso, P.

AU - Amendola, A.

AU - Paglia, M. G.

AU - Colizzi, V.

AU - Poccia, F.

PY - 2000

Y1 - 2000

N2 - γδ T lymphocytes recognize non-peptidic microbial antigens without antigen processing and major histocompatibility complex (MHC) restriction, representing an early defence mechanism against invading pathogens. As a defective response to non-peptidic antigens was observed in human immunodeficiency virus-positive (HIV+) persons, the aims of this study were twofold: to analyse the incidence of γδ T-cell anergy in HIV+ patients with opportunistic infections/co-infections (HIV-OIC), and to investigate the role of highly active antiretroviral therapy (HAART) on γδ T-cell functions. Peripheral γδ T-cell distribution and in vitro reactivity to a non-peptidic mycobacterial antigen, isopentenyl pyrophosphate (IPP), were analysed. γδ T-cell subset distribution was altered more in HIV-OIC patients than in asymptomatic HIV+ subjects (HIV-ASY). Specifically, the Vδ2/Vδ1 ratio was inverted as a consequence of a decrease in Vδ2 T-cell number. Moreover, IPP-stimulated Vδ2 T cells from the HIV-OIC group displayed a major defect in interferon-γ (IFN-γ) production. Interestingly, HAART induced a sustained recovery of naive CD45RA+ and CD62L+ T cells and restored γδ T-cell function. Accordingly, in vitro CD45RA depletion resulted in γδ T-cell hyporesponsiveness. Altogether, the incidence of γδ T-cell anergy was increased in HIV-OIC patients and dependent on CD45RA helper function. Moreover, HAART was able to restore γδ T-cell reactivity, extending the immune recovery to non-peptidic microbial antigens.

AB - γδ T lymphocytes recognize non-peptidic microbial antigens without antigen processing and major histocompatibility complex (MHC) restriction, representing an early defence mechanism against invading pathogens. As a defective response to non-peptidic antigens was observed in human immunodeficiency virus-positive (HIV+) persons, the aims of this study were twofold: to analyse the incidence of γδ T-cell anergy in HIV+ patients with opportunistic infections/co-infections (HIV-OIC), and to investigate the role of highly active antiretroviral therapy (HAART) on γδ T-cell functions. Peripheral γδ T-cell distribution and in vitro reactivity to a non-peptidic mycobacterial antigen, isopentenyl pyrophosphate (IPP), were analysed. γδ T-cell subset distribution was altered more in HIV-OIC patients than in asymptomatic HIV+ subjects (HIV-ASY). Specifically, the Vδ2/Vδ1 ratio was inverted as a consequence of a decrease in Vδ2 T-cell number. Moreover, IPP-stimulated Vδ2 T cells from the HIV-OIC group displayed a major defect in interferon-γ (IFN-γ) production. Interestingly, HAART induced a sustained recovery of naive CD45RA+ and CD62L+ T cells and restored γδ T-cell function. Accordingly, in vitro CD45RA depletion resulted in γδ T-cell hyporesponsiveness. Altogether, the incidence of γδ T-cell anergy was increased in HIV-OIC patients and dependent on CD45RA helper function. Moreover, HAART was able to restore γδ T-cell reactivity, extending the immune recovery to non-peptidic microbial antigens.

UR - http://www.scopus.com/inward/record.url?scp=0034243696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034243696&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2567.2000.00068.x

DO - 10.1046/j.1365-2567.2000.00068.x

M3 - Article

C2 - 10929075

AN - SCOPUS:0034243696

VL - 100

SP - 481

EP - 486

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -